The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1217
September 12, 2005
View Complete Issue         Table of Contents 2019 
Pregabalin (Lyrica) for Neuropathic Pain and Epilepsy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Pregabalin (Lyrica) for Neuropathic Pain and Epilepsy
September 12, 2005 (Issue: 1217)
Pregabalin (Lyrica - Pfizer), a structural analog of gamma-aminobutyric acid (GABA) similar to gabapentin (Neurontin - Pfizer, and others), which recently became available generically, has been approved by the FDA for treatment of neuropathic pain...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Pregabalin (Lyrica) for Neuropathic Pain and Epilepsy
Article code: 1217b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.